Burning Rock Biotech (BNR) Non-Current Assets (2019 - 2025)

Burning Rock Biotech's Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.5 million for Q4 2025.

• In Q4 2025, Non-Current Assets fell 23.79% year-over-year to $11.5 million; the TTM figure through Dec 2025 stood at $11.5 million (down 23.79% YoY), while the FY2025 annual figure was $11.7 million, down 21.46% from the prior year.
• Non-Current Assets was $11.5 million for Q4 2025 at Burning Rock Biotech, up from $10.2 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $71.6 million in Q4 2021 to a low of $10.2 million in Q3 2025.
• Historically, Non-Current Assets has averaged $35.9 million across 5 years, with a median of $31.5 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Non-Current Assets surged 240.35% in 2021, then sank 64.09% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $71.6 million in 2021, then sank by 35.43% to $46.2 million in 2022, then slumped by 53.15% to $21.7 million in 2023, then tumbled by 30.12% to $15.1 million in 2024, then fell by 23.79% to $11.5 million in 2025.
• The last three Non-Current Assets figures came in at $11.5 million (Q4 2025), $10.2 million (Q3 2025), and $11.7 million (Q2 2025), per Business Quant data.